Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents

Ann Rheum Dis. 2005 Dec;64(12):1807. doi: 10.1136/ard.2005.040436.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Autoantibodies / blood*
  • Humans
  • Peptides, Cyclic / immunology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Autoantibodies
  • Peptides, Cyclic
  • Tumor Necrosis Factor-alpha
  • cyclic citrullinated peptide